PRO MEDICUS LIMITED — Director's Dealing 2026

Feb 24, 2026

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Anthony Barry HALL
Date of last notice	23 December 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Ordinary fully paid shares in Pro MedicusLimited held by Research Corporation Pty Ltdas trustee for the Anthony Hall Family Trust.
Date of change	24 February 2026
No. of securities held prior to change	24,148,520 ordinary shares consisting off: -23,200,000 ordinary shares heldunder Anthony Barry HALL867,500 ordinary shares held underAkay Superannuation Fund46,020 ordinary shares held underResearch Corporation Pty Ltd astrustee for the Anthony Hall FamilyTrust35,000 ordinary shares held byAnthony Hall ATF Anthony HallTestamentary Trust

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [409 x 384] intentionally omitted <==

----- Start of picture text ----- Class Ordinary sharesNumber acquired 8,500Number disposed nilValue/Consideration $110.13 per shareNote: If consideration is non-cash, provide details and estimated valuationNo. of securities held after change 24,157,020 ordinary shares consisting off: - 23,200,000 ordinary shares heldunder Anthony Barry HALL 867,500 ordinary shares held underAkay Superannuation Fund 54,520 ordinary shares held underResearch Corporation Pty Ltd astrustee for the Anthony Hall FamilyTrust 35,000 ordinary shares held byAnthony Hall ATF Anthony HallTestamentary Trust.Nature of change On market tradeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior-written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

For and on behalf of Pro Medicus Limited

==> picture [132 x 60] intentionally omitted <==

Danny English Company Secretary 25 February 2026

• See chapter 19 for defined terms.

Appendix 3Y Page 3